Literature DB >> 8957479

Parathyroidectomy in Maryland: effects of an endocrine center.

H Chen1, M A Zeiger, T A Gordon, R Udelsman.   

Abstract

BACKGROUND: Surgery for hyperparathyroidism is associated with high cure rates and low morbidity and mortality when performed by experienced surgeons. We wanted to determine whether referral of patients with hyperparathyroidism to an endocrine surgery center has an impact on patient outcomes and costs.
METHODS: Data from 901 patients who underwent parathyroidectomy recorded in the Maryland inpatient discharge database between 1990 and 1994 at 52 hospitals were compared with 169 consecutive patients who underwent surgical exploration by one surgeon (R.U.) at the Johns Hopkins Hospital.
RESULTS: Although in 47 of 52 hospitals fewer than 10 parathyroidectomies were performed each year, in these hospitals four of five related deaths occurred before patient discharge. The percentage of parathyroidectomies in Maryland performed by one endocrine surgeon has increased from 8% in 1990 to 21% in 1994 and is associated with a 97% cure rate and no mortality. Moreover, while hospital length of stay (LOS) in the state has decreased from 7 to 3.1 days, LOS for the high-volume provider has declined to a mean of 1.3 days.
CONCLUSIONS: Patients with hyperparathyroidism are increasingly referred to an endocrine surgery center, which results in a high cure rate, low morbidity, no mortality, and a shorter LOS. Improved surgical outcomes and lower costs depend on an experienced surgeon and argue for the referral of these patients to endocrine surgery centers.

Entities:  

Mesh:

Year:  1996        PMID: 8957479     DOI: 10.1016/s0039-6060(96)80039-0

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  24 in total

1.  Surgery for primary hyperparathyroidism: what is the best approach?

Authors:  Herbert Chen
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

2.  [Current thyroid and parathyroid surgery].

Authors:  H Dralle
Journal:  Chirurg       Date:  2010-07       Impact factor: 0.955

Review 3.  Influence of surgical volume on operative failures for hyperparathyroidism.

Authors:  Barbara Zarebczan; Herbert Chen
Journal:  Adv Surg       Date:  2011

Review 4.  Intraoperative parathyroid hormone monitoring.

Authors:  William B Inabnet
Journal:  World J Surg       Date:  2004-11-04       Impact factor: 3.352

5.  Unilateral surgery for hyperparathyroidism: indications, limits, and late results--new philosophy or expensive selection without improvement of surgical results?

Authors:  Pierre-E Mortier; Marta M Mozzon; Olivier P Fouquet; Benoit C Soudan; Damien G Huglo; Jean-F Cussac; Charles A G Proye
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

6.  The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing.

Authors:  Fumito Ito; Rebecca Sippel; Julie Lederman; Herbert Chen
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

7.  A rising ioPTH level immediately after parathyroid resection: are additional hyperfunctioning glands always present? An application of the Wisconsin Criteria.

Authors:  Mackenzie R Cook; Susan C Pitt; Sarah Schaefer; Rebecca Sippel; Herbert Chen
Journal:  Ann Surg       Date:  2010-06       Impact factor: 12.969

8.  1112 consecutive bilateral neck explorations for primary hyperparathyroidism.

Authors:  John Allendorf; Mary DiGorgi; Kathryn Spanknebel; William Inabnet; John Chabot; Paul Logerfo
Journal:  World J Surg       Date:  2007-08-31       Impact factor: 3.352

Review 9.  Parathyroid conditions in childhood.

Authors:  Jocelyn F Burke; Herbert Chen; Ankush Gosain
Journal:  Semin Pediatr Surg       Date:  2014-03-15       Impact factor: 2.754

10.  Radioguided parathyroidectomy is equally effective for both adenomatous and hyperplastic glands.

Authors:  Herbert Chen; Eberhard Mack; James R Starling
Journal:  Ann Surg       Date:  2003-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.